CHONGQING, CHINA - OCTOBER 31: The Regeneron webpage is displayed on a smartphone in front of the ... More Regeneron Pharmaceuticals, Inc. logo on October 31, 2024 in Chongqing, China. (Photo by Cheng Xin/Getty Images)Getty Images Regeneron Pharmaceuticals (NASDAQ:REGN) shares witnessed a notable 19% decline on Friday, May 30, in the wake of the unexpected failure of itepekimab, its chronic obstructive pulmonary disease (COPD) treatment in conjunction with Sanofi, during a late-stage clinical trial. One of the two trials did not achieve its primary endpoint, which is a significant setback...
This photograph shows macaron pastries with the Snapchat logo during the inauguration of Snapchat ... More France headquarters in Paris on May 19, 2025. (Photo by JOEL SAGET / AFP) (Photo by JOEL SAGET/AFP via Getty Images)AFP via Getty Images Snap (NYSE: SNAP) stock has fallen more than 20% this year. In fact, the stock has decreased over 50% from its peak in July of last year. It was trading at around $8 per share at the close of the market yesterday. This recent poor performance can be linked to...
INDIA - 2025/05/20: In this photo illustration, a MERCK logo is seen displayed on a smartphone and ... More in the background. (Photo Illustration by Avishek Das/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty Images Merck (NYSE:MRK) stock has experienced a significant 22% decline this year, sharply underperforming the broader S&P 500 index, which is down only 1%. This downturn can be attributed to several factors: a lowered guidance for 2025 and growing concerns about the long-term growth prospects of its blockbuster drugs, Keytruda and Gardasil. Specifically, weak sales of...